Article

Alaska Dispatch NewsAlaska Dispatch News on 2023-03-02 02:34

Novavax was a COVID vaccine underdog. Now it’s in financial trouble.

Maryland-based Novavax, which received $1.8 billion from Operation Warp Speed, says it may not continue as a “going concern.”

Related news